No pricking or unpractical transmitters. The Sencell micro sensor will be injected under the skin on your wrist and operate independently to provide you with continuous glycemic information.

Read the glucose data as often as you want on your smart device.

The wireless, real time data transfer, with alarm functions of the Sencell, shall warn you of high and low glucose levels.

In order to help as many people as possible, the Sencell will be designed to have as low cost as possible.

The osmotic sensor is an implantable 3D printed nano-sensor for subcutaneous location, minimum 6 months usage time, wireless, continuous, read out unit real time glucose measurement for diabetes management.

The main objective of the Sencell Implantable Miniaturized Osmotic Sensor Device is to provide a convenient, efficient, reliable, painless, accurate and durable continuous glucose measurement (CGM) solution at a low cost for daily use to people with diabetes. The unique and advanced technology of Sencell offers a novel and disruptive technology for the global market.

The Sencell glucose monitoring system includes an osmotic pressure sensor (sensor core), transmitter (sensor electronics) and a mobile medical application (reader) to continuously measure glucose in the interstitial fluid.

The sensor device will be further miniaturized to meet the anticipated final size specifications, to become implantable with a simple insertion procedure and to improve performance with respect to accuracy, sensitivity, stability and robustness. A second source for both the glucose and the pressure information will be introduced by a cantilever nanoscale 3D printed technology.

The cantilever based glucose sensor will be used as a reference glucose sensor recalibrating signal drift in the osmotic pressure sensor approach. The sensor (with dimensions in the µm scale) will be implemented on the surface of the osmotic chamber with direct access to the interstitial fluid. The overall size of the two cantilevers is about 500 µm in substrate length and1 mm in substrate width. The cantilevers are about 50×50 µm² (length × width) and feature a thickness of 100 nm to 300 nm. These small dimensions allow easy incorporation of the cantilever array in the existing Sencellimplant designs. Additionally, the cantilevers’ small dimensions enable a high sensitivity.

The proposed use of the nano3DSense™-technology allows for a high degree of pressure transducer miniaturization and enables to easily incorporate even a second pressure transducer allowing to measure changes in external pressure (pressure reference). The strain sensors are directly 3D-printed onto the membrane with the nano3DSense™-printing technology. In this way, the transducer membrane can be made of any material, including biocompatible metals (e.g. titanium).